Hospers GAP - Search Results

1

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.

Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, Roodvoets AGH, Nagtegaal ID, Beets-Tan RGH, Blomqvist LK, Fokstuen T, Ten Tije AJ, Capdevila J, Hendriks MP, Edhemovic I, Cervantes A, Nilsson PJ, Glimelius B, van de Velde CJH, Hospers GAP; RAPIDO collaborative investigators. Bahadoer RR, et al. Among authors: hospers gap. Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7. Lancet Oncol. 2021. PMID: 33301740 Clinical Trial.

2

Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.

Mulder NH, Dolsma WV, Mulder PO, De Vries EG, Willemse PH, Sleijfer DT, Hospers GA, Van der Graaf WT. Mulder NH, et al. Anticancer Res. 1995 Jul-Aug;15(4):1565-8. Anticancer Res. 1995. PMID: 7654046 Clinical Trial.

3

Long-term haematological recovery following high-dose chemotherapy with autologous bone marrow transplantation or peripheral stem cell transplantation in patients with solid tumours.

Nieboer P, de Vries EG, Mulder NH, Sleijfer DT, Willemse PH, Hospers GA, Gietema JA, Sluiter WJ, van Der Graaf WT. Nieboer P, et al. Bone Marrow Transplant. 2001 May;27(9):959-66. doi: 10.1038/sj.bmt.1703030. Bone Marrow Transplant. 2001. PMID: 11436106

4

Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.

Nieboer P, Mulder NH, Van Der Graaf WT, Willemse PH, Hospers GA. Nieboer P, et al. Anticancer Res. 2001 Jul-Aug;21(4B):3115-6. Anticancer Res. 2001. PMID: 11712820

5

Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinoma.

van Steijn JH, Nieboer P, Hospers GA, de Vries EG, Mulder NH. van Steijn JH, et al. Anticancer Res. 2001 Sep-Oct;21(5):3699-700. Anticancer Res. 2001. PMID: 11848546

6

A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis.

Reerink O, Verschueren RC, Szabo BG, Hospers GA, Mulder NH. Reerink O, et al. Eur J Cancer. 2003 Jan;39(2):192-5. doi: 10.1016/s0959-8049(02)00557-9. Eur J Cancer. 2003. PMID: 12509951

7

Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy.

Reerink O, Karrenbeld A, Plukker JT, Verschueren RC, Szabó BG, Sluiter WJ, Hospers GA, Mulder NH. Reerink O, et al. Anticancer Res. 2004 Mar-Apr;24(2C):1217-21. Anticancer Res. 2004. PMID: 15154650 Free article.

8

5FU and oxaliplatin-containing chemotherapy in two dihydropyrimidine dehydrogenase-deficient patients.

Reerink O, Mulder NH, Szabo BG, Hospers GA. Reerink O, et al. Anticancer Res. 2004 May-Jun;24(3b):1969-71. Anticancer Res. 2004. PMID: 15274386 Free article.

9

Treatment of locally recurrent rectal cancer, results and prognostic factors.

Reerink O, Mulder NH, Botke G, Sluiter WJ, Szabó BG, Plukker JT, Verschueren RC, Hospers GA. Reerink O, et al. Eur J Surg Oncol. 2004 Nov;30(9):954-8. doi: 10.1016/j.ejso.2004.07.013. Eur J Surg Oncol. 2004. PMID: 15498640

10

Developments in treatment of primary irresectable rectal cancer.

Reerink O, Mulder NH, Szabo BG, Sluiter WJ, Wiggers T, Bongaerts AH, Hospers GA. Reerink O, et al. Colorectal Dis. 2004 Nov;6(6):406-17. doi: 10.1111/j.1463-1318.2004.00602.x. Colorectal Dis. 2004. PMID: 15521928 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters